Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Prostate|March 25, 2018
2-fluoro-5-maleimidobenzoic acid-linked albumin drug (MAD) delivery for selective systemic targeting of metastatic prostate cancerEmmanuel S Akinboye, Oliver C Rogers, John T IsaacsBioorganic & Medicinal Chemistry|November 21, 2017
Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivativesEmmanuel S Akinboye, Marc D Rosen, Oladapo Bakare, et al.Asian Journal of Urology|February 19, 2019
Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancerEmmanuel S Akinboye, W Nathaniel Brennen, Samuel R Denmeade, et al.ACS Omega|May 12, 2025
Development of a Prostate-Specific Antigen Targeted Dual Drug Conjugate for Prostate Cancer TherapyOluwanifemi B Owoseni, Tayo Alex Adekiya, Emmanuel S Akinboye, et al.Acta Crystallographica. Section E, Structure Reports Online|April 26, 2014
4-Hy-droxy-5-meth-oxy-N,1-dimethyl-2-oxo-N-[4-(tri-fluoro-meth-yl)phen-yl]-1,2-di-hydro-quinoline-3-carboxamideEmmanuel S Akinboye, Ray J Butcher, Sema Ozturk Yildirim, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphth-yl)-2-chloro-N-(2-chloro-benzoyl)benzamideEmmanuel S Akinboye, Ray J Butcher, Yakini Brandy, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphth-yl)-4-fluoro-N-(4-fluoro-benzo-yl)benzamideEmmanuel S Akinboye, Ray J Butcher, Dwayne A Wright, et al.The Prostate|February 3, 2016
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategyEmmanuel S Akinboye, W Nathaniel Brennen, D Marc Rosen, et al.Journal of Medicinal Chemistry|August 8, 2012
Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancerEmmanuel S Akinboye, Marc D Rosen, Samuel R Denmeade, et al.Bioorganic & Medicinal Chemistry|July 19, 2015
Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell linesEmmanuel S Akinboye, Zebalda D Bamji, Bernard Kwabi-Addo, et al.Pageof 2